quantitative
Analysis v1
39
0
After 6 months of oral semaglutide treatment, 32 people with type 2 diabetes had lower liver enzyme levels, indicating improved liver health.
Scientific Claim
In 32 adults with type 2 diabetes, oral semaglutide use over 26 weeks was associated with a 17.4% reduction in ALT levels (from 28.7 to 23.7 IU/L) at 6 months.
Original Statement
“ALT levels were found to be significantly lower than baseline after 6 months of therapy ( Table 3 ).”
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
association
Can only show association/correlation
Assessment Explanation
The study is observational with no control group, so causation cannot be established. The use of 'associated with' correctly reflects the evidence.
Evidence from Studies
Supporting (1)
39
Contradicting (0)
0
No contradicting evidence found